PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 34–34 | Cite as

Substantial savings by boosting biosimilar prescribing in France

Meeting report


  1. Ade A, et al. A New French Financial Incentive to Boost Insulin and Etanercept Biosimilars Prescribing: Simulation of Economic Impacts for the Public Hospitals of Paris. 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PHP72, 10 Nov 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations